eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2018;6(2):33-33 doi: 10.15171/jpd.2018.12
Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient

Hypothesis

Mansoor Karimifar 1 * , Mozhgan Karimifar 2

1 Department of Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.


*Corresponding author: Mansoor Karimifar,
Email: karimifar@med.mui.ac.ir


Abstract

Implication for health policy/practice/research/medical education

Treatment for renal failure, especially those who undergo dialysis, is very difficult and challenging. Bisphosphonates have been administered for the treatment of osteoporosis for many years, but they are administered with caution in those who have renal failure. With the introduction of Prolia as an anti-osteoporosis drug, the hope was created to treat patients with kidney failure.



Notes

Please cite this paper as: Karimifar M, Karimifar M. Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient. J Parathyr Dis. 2018;6(2):33. DOI: 10.15171/jpd.2018.12.

Copyright © 2018 The Author(s); Published by Nickan Research Institute. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Mansoor Karimifar
Articles by Mozhgan Karimifar
Similar articles
Related articles

PubMed
Articles by Mansoor Karimifar
Articles by Mozhgan Karimifar


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute